Abstract:Objective To evaluate the sensitivity, specificity and clinical significance of Lunx mRNA in surveying micrometastasis by sampling peripheral blood of lung cancer patients, studying the early diagnosis of lung cancer metastasis. Methods From March 2004 to February 2005,Reverse transcription-polymerase chain reaction(RT-PCR) was used to detect Lunx mRNA of peripheral blood of 60 lung cancer patients(lung cancer group). Peripheral blood of 20 patients with pulmonary benign lesions (pulmonary benign lesions group) and 10 normal healthy volunteers (control group) were used as control. Results (1) In the lung cancer group, Lunx mRNA were expressed positive in 28(46.7%) patients. All the pulmonary benign lesions group (0/20) and the control group (0/10) were expressed negative. (2) One of the 12 stage I patients with lung cancer (8.3%) was positive for Lunx mRNA, 5 of the 15 stage Ⅱ patients (33.3%) were positive, 22 of the 33 stage Ⅲ patients (66.7%) were positive. Comparing the positive rate of these groups, there was no statistically difference between stage Ⅰ and stage Ⅱ, but the difference between stage Ⅰ+ stage Ⅱ and stage Ⅲ was significant (χ2=15.88, P=0.000). (3) In 38 adenocarcinoma, 17 were positive for Lunx mRNA. In 14 squamous carcinoma, 7 were positive. All the 3 adenosquamous carcinoma expressed positive. 1 of 3 small cell lung cancer was positive, 1 large cell carcinoma and 1 carcinoma sarcomatodes expressed negative. Comparing the positive rate of these groups, there was no statistically difference among them. (4) By follow-up till March 2005, 10 lung cancer patients were found metastasis. Among them, 9 were positive for Lunx mRNA expression, and 1 was negative. Conclusion Lunx mRNA has high sensitivity and specificity in surveying micrometastasis by sampling peripheral blood. It would likely to be an proper gene for the detection of micrometastasis in lung cancer patients.

Clinical Significance of Lunx mRNA Detection in the Peripheral Blood of Non-Small Cell Lung Cancer Patients

Detection and clinical significance of Lunx mRNA in peripheral blood of patients with non-small cell lung cancer

Clinical Significance of Lunx mRNA Expression in Peripheral Blood of Lung Cancer Patients

[Feasibility and Its Clinical Significance of Detection of LUNX Mrna Expression in Diagnosis of Micrometastasis for Non-Small Cell Lung Cancer].

Diagnostic Utility of LunX Mrna in Peripheral Blood and Pleural Fluid in Patients with Primary Non-Small Cell Lung Cancer

[LUNX mRNA in regional lymph nodes of non-small cell lung cancer patients by RT-PCR and its clinical significance]

Detection and Significance of Lunx Mrna in Peripheral Blood of Patients with Non-small Cell Lung Cancer by FQ-RT-PCR

Mrna Expression of Lunx in Regional Lymph Nodes of Non-Small Cell Lung Cancer and Its Correlation with Prognosis

Clinical Significance of Expressions of LunX and CK19 Mrna in Peripheral Blood in Lung Cancer

A Combination of LUNX and KS1/4 Accurately Detects Lymph Node Metastasis in Non-Small Cell Lung Cancer

Detection of Micrometastases of Lung Cancer by Using Lunx Mrna Specific Reverse Transcription-Polymerase Chain Reaction

Clinical Significance of Detecting CK19mRNA in the Peripheral Blood in Non-Small Cell Lung Cancer Patients

Significance of Combined Detection of LunX Mrna and Tumor Markers in Diagnosis of Lung Carcinoma.

Detection of Micrometastases of Non-small Cell Lung Cancer by Using CK19 mRNA and LUNX mRNASpecific Reverse Transcription-polymerase Chain Reaction

Diagnostic value of detection of lung-specific X protein gene mRNA in the peripheral blood of patients with lung cancer using real-time RT-PCR assay

Combination Detection of Three Gene Markers Expressed in Circulating Cancer Cells of Non-Small Cell Lung Cancer

Clinical Significance of Cytokeratin 19 Mrna in the Peripheral Blood of Non-Small Cell Lung Cancer

[Detection of Micrometastasis in Mediastinal Lymph Nodes in Operable Non-Small Cell Lung Cancers].

Significance of Expressions of CK19, LunX and KS1/4 in Lymph Nodes in Diagnosis of Micrometastases in Patients with Non-Small Cell Lung Cancer

Expression of microRNA-150 in Peripheral Blood and Its Clinical Significance in Patients with Non-Small Cell Lung Cancer

Expression of CK19 Mrna and LUNX Mrna Detected by Nested PCR for Diagnosis of Lymph Node Micrometastasis in Non Small Cell Lung Cancer